A9R-77171-81198
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 913 / CA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2020-12-26
- 2021-01-04
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fever · Nausea, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-21
- 2021-01-28
-
2021-02-04
Survey response — day 28, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: tested positive twice for covid 19MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 28, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-04-28
-
2021-04-28
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 28, dose 2
Symptoms: tested positive twice for covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release